Fully automated filling

In order to meet its customers’ diversified requirements, Axellia recently began producing dosage forms of APIs in injectables. This enables the company to offer both raw APIs as well as finished products in an injectable format.

Axellia’s existing filling line for injectables was exclusively devoted to powder filling, which was limited to only a few API products. To expand capacity for finished injectables and extend its portfolio to different API products, Axellia sought a liquid filling solution with sterile processing and lyophilization capabilities. Due to the unstable nature of certain API products, they must be freeze-dried into a dry powder form, after being filled into injectable vials, to ensure a reasonable shelf life of the finished product.

…

Dowload (PDF, 235 KB)

For more information please contact:

Klaus Schreiber
Phone +49 7951 402 367
klaus.schreiber@bosch.com

Ralph Pfister
Phone +49 711 811 57 293
ralph.pfister@bosch.com